TABLE 2
FROM:
Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension
E Teijeira-Fernandez, S Eiras, L Grigorian-Shamagian, A Fernandez, B Adrio and J R Gonzalez-Juanatey
BACK TO ARTICLETable 2. Relationship between hypertension, epicardial adipose tissue adiponectin expression and other confounding factors
| Odds ratio (95% CI) | P-value | |
|---|---|---|
| EAT adiponectin mRNA (per a.u.)a | 0.828 (0.707–0.971) | 0.020 |
| Age (per year) | 1.061 (1.000–1.126) | 0.048 |
| Gender (female) | 2.932 (0.886–9.704) | 0.08 |
| Body mass index (per kg/m2) | 1.111 (0.954–1.292) | 0.18 |
| Coronary artery disease | 0.752 (0.247–2.286) | 0.62 |
| Heart failure | 0.587 (0.188–1.828) | 0.36 |
| Diabetes mellitus | 0.708 (0.239–2.102) | 0.53 |
| Triglycerides (per mg/100 ml) | 1.010 (0.996–1.025) | 0.17 |
Abbreviations: a.u., arbitrary units; CI, confidence interval; EAT, epicardial adipose tissue; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
R 2 (Cox)=0.183.
N=101.
a Per GAPDH unit.
Results of multivariable logistic regression analysis.
